ClinicalTrials.Veeva

Menu

Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. (TAVI QdV)

E

Elsan

Status

Enrolling

Conditions

Transfemoral Approach
Aortic Valve Replacement
Quality of Life

Treatments

Other: Quality of life questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05539937
2022-A00820-43

Details and patient eligibility

About

In order to overcome the shortcomings of the assessment questionnaires currently available on the assessment of overall quality of life, the "Toronto Aortic Stenosis Quality of Life Questionnaire" (TASQ) was developed as a specific assessment tool for the impact of severe aortic stenosis in elderly patients, through 16 questions covering 5 domains: symptoms and physical limitations, emotional impact and expectations following TAVI, as well as social limitations incurred.

A better knowledge and understanding of the clinical outcomes and quality of life of elderly patients with severe symptomatic aortic stenosis at 12 months of follow-up of a TAVI procedure would further optimize the clinical decision-making process and patient selection who will benefit the most from this intervention in the long term.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male, female, over 18 years old,
  • All patients who will have transfemoral percutaneous aortic valve replacement (TAVI) with implantation of a valve delivered on a balloon,
  • Patient able to understand the study, and answer the TASQ questionnaire,
  • Affiliation to a social security scheme or beneficiary of such a scheme,
  • Patient having signed the free and informed consent.

Exclusion criteria

  • Minor,
  • Disorder of comprehension and/or expression,
  • Patients unable to answer questions due to an underlying cognitive deficit or physical disability,
  • Patients treated with a self-expanding valve,
  • Refusal to participate in the study,
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision,
  • Pregnant, parturient, or breast-feeding patient.

Trial design

140 participants in 1 patient group

Patient with percutaneous aortic valve replacement via the transfemoral approach
Treatment:
Other: Quality of life questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Jean-François Oudet; Marie-Jeanne Bertrand, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems